RecruitingNot ApplicableNCT07792083

Microbiological and Biochemical Profiling of Amniotic Fluid in Women With Short Cervix or Premature Rupture of Membranes


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

300 participants

Start Date

Dec 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims at assessing the efficacy, reliability, and clinical impact of Amniotic Fluid analysis by Nanopore DNA sequencing compared to the standard bacterial cultures in detecting intra-amniotic/inflammation in patients with short cervix or premature rupture of membranes.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying amniotic fluid collection for people with prom, preterm (pregnancy) and short cervix. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERamniotic fluid collection

Amniotic fluid by amniocentesis or by sterile cervical aspiration via the vagina


Locations(1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, RM, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07792083


Related Trials